245 related articles for article (PubMed ID: 2899630)
21. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
Ando T; Momota K; Sugiyama M
Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
24. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of acarbose. Part II: Distribution to and elimination from tissues and organs following single or repeated administration of [14C]acarbose to rats and dogs.
Ahr HJ; Krause HP; Siefert HM; Steinke W; Weber H
Arzneimittelforschung; 1989 Oct; 39(10):1261-7. PubMed ID: 2610718
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of 3-deoxy-4-sulphohexosulose, a reaction product of sulphite in foods, by rat and mouse.
Walker R; Mendoza-Garcia MA; Quattrucci E; Zerilli M
Food Chem Toxicol; 1983 Jun; 21(3):291-7. PubMed ID: 6683226
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and metabolism of HOE 077. Preclinical studies.
Kellner HM; Volz M; Badder E; Kürzel GU; Eckert HG
J Hepatol; 1991; 13 Suppl 3():S48-61; discussion S62. PubMed ID: 1667669
[TBL] [Abstract][Full Text] [Related]
30. Absorption, distribution and excretion of DL-gamma-amino-beta-hydroxybutyric acid-1-14C (GABOB-1-14C) in the rat.
Bonardi G; Mondino A; Silvestri S; Zanolo G
Arzneimittelforschung; 1981; 31(11):1910-3. PubMed ID: 7198473
[TBL] [Abstract][Full Text] [Related]
31. Distribution and excretion of teicoplanin in rats after single and repeated intravenous administration.
Zanolo G; Bernareggi A; Cavenaghi L; Giachetti C; Tognolo C
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():85-93. PubMed ID: 1840327
[TBL] [Abstract][Full Text] [Related]
32. Excretion of radioactivity in faeces and urine of rats injected with 3H,14C-lipopolysaccharide.
Kleine B; Freudenberg MA; Galanos C
Br J Exp Pathol; 1985 Jun; 66(3):303-8. PubMed ID: 4005148
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
34. Tissue distribution, metabolism, and excretion of 14C-TCDD in a TCDD-susceptible and a TCDD-resistant rat strain.
Pohjanvirta R; Vartiainen T; Uusi-Rauva A; Mönkkönen J; Tuomisto J
Pharmacol Toxicol; 1990 Feb; 66(2):93-100. PubMed ID: 2315270
[TBL] [Abstract][Full Text] [Related]
35. [Studies on the metabolic fate of 14C-rokitamycin. Absorption, distribution, metabolism and excretion in infant rats].
Sakai A; Iwasaki M; Suzuki T; Morishita M; Muranishi S
Jpn J Antibiot; 1988 Jul; 41(7):797-808. PubMed ID: 3172452
[TBL] [Abstract][Full Text] [Related]
36. The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.
Hawkins DR; Weston KT; Chasseaud LF; Darragh A; O'Kelly A
Eur J Drug Metab Pharmacokinet; 1980; 5(3):135-43. PubMed ID: 7202431
[TBL] [Abstract][Full Text] [Related]
37. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
38. Tissue disposition and excretion of gold and 14C in rats treated with sodium aurothio[1,4-14C]malate or thio [1,4-14C] malic acid.
Taylor A; King LJ; Marks V
Xenobiotica; 1985 Mar; 15(3):221-6. PubMed ID: 3927598
[TBL] [Abstract][Full Text] [Related]
39. Blood level, distribution, metabolite pattern and excretion of [14C]alinidine in mice and rats.
Bechtel WD; Richter I
Eur J Drug Metab Pharmacokinet; 1986; 11(3):175-86. PubMed ID: 3816873
[TBL] [Abstract][Full Text] [Related]
40. Disposition of 2-(2-quinolyl)-1,3-indandione (D. C. yellow #11) in rats dosed orally or intravenously.
el Dareer SM; Kalin JR; Tillery KF; Hill DL
J Toxicol Environ Health; 1988; 23(3):385-93. PubMed ID: 3351983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
